Archit Organosys Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Chemicals kazanç büyümesi	21.1%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

BSE:524640 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2024	1,092	26	N/A	N/A	N/A
3/31/2024	1,132	33	83	101	N/A
12/31/2023	1,288	34	N/A	N/A	N/A
9/30/2023	1,264	61	52	173	N/A
6/30/2023	1,284	88	N/A	N/A	N/A
3/31/2023	1,278	113	12	172	N/A
12/31/2022	1,075	113	N/A	N/A	N/A
9/30/2022	1,238	111	15	146	N/A
6/30/2022	1,383	94	N/A	N/A	N/A
3/31/2022	1,367	82	-2	106	N/A
12/31/2021	1,409	79	N/A	N/A	N/A
9/30/2021	1,276	74	10	56	N/A
6/30/2021	1,110	71	N/A	N/A	N/A
3/31/2021	945	50	80	111	N/A
12/31/2020	807	29	N/A	N/A	N/A
9/30/2020	735	8	-46	19	N/A
6/30/2020	699	-8	N/A	N/A	N/A
3/31/2020	767	-8	25	77	N/A
12/31/2019	823	0	N/A	N/A	N/A
9/30/2019	803	-19	180	190	N/A
6/30/2019	831	-25	N/A	N/A	N/A
3/31/2019	840	-47	-11	27	N/A
12/31/2018	993	-41	N/A	N/A	N/A
9/30/2018	1,063	-10	N/A	N/A	N/A
6/30/2018	922	11	N/A	N/A	N/A
3/31/2018	815	5	N/A	-38	N/A
12/31/2017	575	-9	N/A	N/A	N/A
9/30/2017	470	-8	N/A	N/A	N/A
6/30/2017	475	-8	N/A	N/A	N/A
3/31/2017	480	17	N/A	23	N/A
12/31/2016	464	22	N/A	N/A	N/A
9/30/2016	468	20	N/A	N/A	N/A
6/30/2016	470	16	N/A	N/A	N/A
3/31/2016	514	15	N/A	9	N/A
12/31/2015	545	14	N/A	N/A	N/A
9/30/2015	542	11	N/A	N/A	N/A
6/30/2015	554	11	N/A	N/A	N/A
3/31/2015	555	8	N/A	17	N/A
12/31/2014	551	9	N/A	N/A	N/A
9/30/2014	546	6	N/A	N/A	N/A
6/30/2014	524	5	N/A	N/A	N/A
3/31/2014	492	6	N/A	11	N/A
12/31/2013	454	5	N/A	N/A	N/A

Archit Organosys Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Archit Organosys Limited Appoints Pruthvik R. Soni as the Company Secretary & Compliance Officer

Archit Organosys Limited Announces Resignation of Purvi S. Mitna as Company Secretary

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited to Report Q2, 2025 Results on Nov 14, 2024

First quarter 2025 earnings released: EPS: ₹0.49 (vs ₹0.77 in 1Q 2024)

Archit Organosys Limited to Report Q1, 2025 Results on Aug 08, 2024

Archit Organosys Limited Appoints Purvi S. Mitna as the Company Secretary & Compliance Officer

Whole Time Director recently bought ₹796k worth of stock

Investor sentiment improves as stock rises 25%

Full year 2024 earnings released: EPS: ₹1.60 (vs ₹5.53 in FY 2023)

New major risk - Market cap size

Archit Organosys Limited to Report Q4, 2024 Results on May 30, 2024

Investor sentiment improves as stock rises 18%

Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million.

Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million.

Now 20% undervalued after recent price drop

New major risk - Market cap size

Third quarter 2024 earnings released: ₹0.22 loss per share (vs ₹1.09 profit in 3Q 2023)

New minor risk - Profit margin trend

Archit Organosys Limited Declares Dividend

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022)

Archit Organosys Limited to Report Q3, 2024 Results on Feb 14, 2024

Upcoming dividend of ₹0.50 per share at 1.0% yield

Archit Organosys Limited Proposes Declare

Archit Organosys Limited to Report Q1, 2024 Results on Aug 14, 2023

Investor sentiment improves as stock rises 16%

Upcoming dividend of ₹0.50 per share at 0.9% yield

Archit Organosys Limited, Annual General Meeting, Aug 22, 2023

Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022)

Archit Organosys Limited Recommends a Final Dividend for the Financial Year Ended March 31, 2023

Chairman & Whole Time Director recently bought ₹507k worth of stock

Chairman & Whole Time Director recently bought ₹1.3m worth of stock

Investor sentiment deteriorated over the past week

Third quarter 2023 earnings released: EPS: ₹1.09 (vs ₹0.99 in 3Q 2022)

Archit Organosys Limited to Report Q3, 2023 Results on Jan 13, 2023

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022)

Archit Organosys Limited to Report Q2, 2023 Results on Nov 11, 2022

Archit Organosys Limited Announces Chief Financial Officer Changes

Investor sentiment improved over the past week

Archit Organosys Limited Approves Dividend

Investor sentiment improved over the past week

Archit Organosys Limited, Annual General Meeting, Sep 08, 2022

First quarter 2023 earnings released: EPS: ₹2.01 (vs ₹1.42 in 1Q 2022)

Archit Organosys Limited to Report Q1, 2023 Results on Jul 25, 2022

Archit Organosys Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022

Investor sentiment improved over the past week

Archit Organosys Limited Announces Appointment of Vijay A. Boliya as Company Secretary and Compliance Officer, Effective March 1, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Archit Organosys Limited Announces Resignation of Anchal Bansal as Company Secretary and Compliance Officer

Second quarter 2022 earnings released: EPS ₹0.68 (vs ₹0.70 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹1.42 (vs ₹0.55 in 1Q 2021)

Independent Director Rajendraprasad Shah has left the company

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹3.33 (vs ₹0.53 loss in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹1.02 (vs ₹0.37 loss in 3Q 2020)

Archit Organosys Limited to Report Q3, 2021 Results on Feb 13, 2021

Investor sentiment improved over the past week

New 90-day high: ₹25.00

New 90-day high: ₹24.55

Investor sentiment deteriorated over the past week

New 90-day high: ₹23.80

Archit Organosys Limited to Report First Half, 2021 Results on Nov 09, 2020

New 90-day high: ₹14.60

Archit Organosys Limited announced that it expects to receive INR 13.75 million in funding

First quarter earnings released

Full year earnings released - ₹0.53 loss per share

New 90-day high - ₹10.56

Full year earnings released - ₹0.53 loss per share